Search research articles
Contact Us
Filters
Showing results (551-560 of 1,095) with videos related to
Page
of 110
Sort By:
Clinical Genitourinary Cancer
|
June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
Giorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Biomed Research International
|
June 11, 2019
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker
Diego Signorelli, Patrizia Giannatempo, Giulia Grazia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and Europe
Zobair M Younossi, Giacomo Germani, Maria Buti, et al.
BMC Gastroenterology
|
July 19, 2011
Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series
Mònica Sabaté, Luisa Ibáñez, Eulàlia Pérez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 15, 2017
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype
M Riveiro-Barciela, M Bes, F Rodríguez-Frías, et al.
Journal of Viral Hepatitis
|
February 28, 2020
Unexpected long-lasting anti-HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?
Mar Riveiro-Barciela, Ariadna Rando-Segura, Ana Barreira-Díaz, et al.
Targeted Oncology
|
September 19, 2014
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
M Donini, S Buti, S Lazzarelli, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study
Maria Buti, Alejandro Franco, Isabel Carmona, et al.
Clinical Medicine Insights. Oncology
|
September 16, 2021
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
Sebastiano Buti, Fabiana Perrone, Teresa Zielli, et al.
European Journal of Public Health
|
July 4, 2025
Blood-borne virus testing in European emergency departments: current evidence and service considerations
Elizabeth Smout, Murad Ruf, Maria Buti, et al.
Page
of 110
Search research articles
Search
Showing results (551-560 of 1,095) with videos related to
Sort By:
Page
of 110
Clinical Genitourinary Cancer
|
June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
Giorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Biomed Research International
|
June 11, 2019
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker
Diego Signorelli, Patrizia Giannatempo, Giulia Grazia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and Europe
Zobair M Younossi, Giacomo Germani, Maria Buti, et al.
BMC Gastroenterology
|
July 19, 2011
Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series
Mònica Sabaté, Luisa Ibáñez, Eulàlia Pérez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 15, 2017
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype
M Riveiro-Barciela, M Bes, F Rodríguez-Frías, et al.
Journal of Viral Hepatitis
|
February 28, 2020
Unexpected long-lasting anti-HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?
Mar Riveiro-Barciela, Ariadna Rando-Segura, Ana Barreira-Díaz, et al.
Targeted Oncology
|
September 19, 2014
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
M Donini, S Buti, S Lazzarelli, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study
Maria Buti, Alejandro Franco, Isabel Carmona, et al.
Clinical Medicine Insights. Oncology
|
September 16, 2021
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
Sebastiano Buti, Fabiana Perrone, Teresa Zielli, et al.
European Journal of Public Health
|
July 4, 2025
Blood-borne virus testing in European emergency departments: current evidence and service considerations
Elizabeth Smout, Murad Ruf, Maria Buti, et al.
Page
of 110